Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors

Biochemical and Biophysical Research Communications

Volumn 387, Issue 1, 2009, Pages 180-185

  Kubota Koketsu, Ritsuko ^a   Mizuta, Hiroyuki ^a   Oshita, Masatoshi ^b   Ideno, Shoji ^b   Yunoki, Mikihiro ^a,b   Kuhara, Motoki ^c   Yamamoto, Naomasa ^d   Okuno, Yoshinobu ^e   Ikuta, Kazuyoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Benesis Corporation   (Japan)

^c Medical & Biological Laboratories Co Ltd   (Japan)

^d OHU UNIVERSITY   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Global epitope; Human monoclonal antibody; Influenza virus; Virus neutralization

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; RNA; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS HEMAGGLUTININ;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGENICITY; ARTICLE; BINDING SITE; CELL STRAIN; CHIMERA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOGLOBULIN VARIABLE REGION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR BINDING; SEROTYPE; VACCINE PRODUCTION; VIRUS NEUTRALIZATION; WESTERN BLOTTING;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; EPITOPE MAPPING; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS;

MURINAE; ORTHOMYXOVIRIDAE;

EID: 67651017498     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.151     Document Type: Article

References (28)

1. Yeh K.M., Chiueh T.S., Siu L.K., Lin J.C., Chan P.K., Peng M.Y., Wan H.L., Chen J.H., Hu B.S., Perng C.L., Lu J.J., and Chang F.Y. Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital. J. Antimicrob. Chemother. 56 (2005) 919-922
2. Traggial E., Becker S., Subbarao K., Kolesnikova L., Uematsu Y., Gismondo M.R., Murphy B.R., Rappuoli R., and Lanzavecchia A. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10 (2004) 871-875
3. Luke T.C., Kilbane E.M., Jackson J.L., and Hoffman S.L. Mata-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?. Ann. Intern. Med. 145 (2006) 599-609
4. Zhou B., Zhong N., and Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N. Engl. J. Med. 357 (2007) 1450-1451
5. Hanson B.J., Boon A.C., Lim A.P., Webb A., Ooi E.E., and Webby R.J. Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respir. Res. 7 (2006) 126
6. Simmons C.P., Bernasconi N.L., Suguitan A.L., Mills K., Ward J.M., Chau N.V., Hien T.T., Sallusto F., Ha do Q., Farrar J., de Jong M.D., Lanzavecchia A., and Subbarao K. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med. 4 (2007) e178
7. Throsby M., van den Brink E., Jongeneelen M., Poon L.L., Alard P., Cornelissen L., Bakker A., Cox F., van Deventer E., Guan Y., Cinatl J., ter Meulen J., Lasters I., Carsetti R., Peiris M., de Kruif J., and Goudsmit J. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 3 (2008) e3942
8. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., Santelli E., Stec B., Cadwell G., Ali M., Wan H., Murakami A., Yammanuru A., Han T., Cox N.J., Bankston L.A., Donis R.O., Liddington R.C., and Marasco W.A. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16 (2009) 265-273
9. Okuno Y., Matsumoto K., Isegawa Y., and Ueda S. Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains. J. Virol. 68 (1994) 517-520
10. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., Zheng N.Y., Mays I., Garman L., Helms C., James J., Air G.M., Capra J.D., Ahmed R., and Wilson P.C. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453 (2008) 667-671
11. Ogura M., Morishima Y., Ohno R., Kato Y., Hirabayashi N., Nagura H., and Saito H. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood 66 (1985) 1384-1392
12. Okuno Y., Isegawa Y., Sasao F., and Ueda S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 67 (1993) 2552-2558
13. Nakagawa N., Kubota R., Morikawa S., Nakagawa T., Baba K., and Okuno Y. Characterization of new epidemic strains of influenza B virus by using neutralizing monoclonal antibodies. J. Med. Virol. 65 (2001) 745-750
14. Nakagawa N., Maeda A., Kase T., Kubota R., and Okuno Y. Rapid detection and identification of two lineages of influenza B strains with monoclonal antibodies. J. Virol. Methods 79 (1999) 113-120
15. Okuno Y., Tanaka K., Baba K., Maeda A., Kunita N., and Ueda S. Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system. J. Clin. Microbiol. 28 (1990) 1308-1313
16. Reineke U., Kramer A., and Schneider-Mergener J. Antigen sequence and library-based mapping of linear and discontinuous protein-protein-interaction sites by spot synthesis. Curr. Top. Microbiol. Immunol. 243 (1999) 23-36
17. Reineke U., Ivascu C., Schlief M., Landgraf C., Gericke S., Zahn G., Herzel H., Volkmer-Engert R., and Schneider-Mergener J. Identification of distinct antibody epitopes and mimotopes from a peptide array of 5520 randomly generated sequences. Immunol. Methods 267 (2002) 37-51
18. National Institute of Infectious Diseases (NIID), Influenza 2005/06 season, Japan, Infectious Agents Surveillance Report (IASR), vol. 321, 2006, pp. 293-294 (in Japanese).
19. National Institute of Infectious Diseases (NIID), Influenza 2006/07 season, Japan, Infectious Agents Surveillance Report (IASR), vol. 333, 2007, pp. 311-313 (in Japanese).
20. Wiley D.C., Wilson I.A., and Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289 (1981) 373-378
21. Underwood P.A. Mapping of antigenic changes in the haemagglutinin of Hong Kong influenza (H3N2) strains using a large panel of monoclonal antibodies. J. Gen. Virol. 62 (1982) 153-169
22. Wilson I.A., Niman H.L., Houghten R.A., Cherenson A.R., Connolly M.L., and Lerner R.A. The structure of an antigenic determinant in a protein. Cell 37 (1984) 767-778
23. Underwood P.A. An antigenic map of the haemagglutinin of the influenza Hong Kong subtype (H3N2), constructed using mouse monoclonal antibodies. Mol. Immunol. 21 (1984) 663-671
24. Kostolansky F., Varecková E., Betáková T., Mucha V., Russ G., and Wharton S.A. The strong positive correlation between effective affinity and infectivity neutralization of highly cross-reactive monoclonal antibody IIB4, which recognizes antigenic site B on influenza A virus haemagglutinin. J. Gen. Virol. 81 (2000) 1727-1735
25. Nakajima S., Nakajima K., Nobusawa E., Zhao J., Tanaka S., and Fukuzawa K. Comparison of epitope structures of H3HAs through protein modeling of influenza A virus hemagglutinin: mechanism for selection of antigenic variants in the presence of a monoclonal antibody. Microbiol. Immunol. 51 (2007) 1179-1187
26. Green N., Alexander H., Olson A., Alexander S., Shinnick T.M., Sutcliffe J.G., and Lerner R.A. Immunogenic structure of the influenza virus hemagglutinin. Cell 28 (1982) 477-487
27. White J.M., and Wilson I.A. Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J. Cell Biol. 105 (1987) 2887-2896
28. Nakajima S., Nobusawa E., and Nakajima K. Variation in response among individuals to antigenic sites on the HA protein of human influenza virus may be responsible for the emergence of drift strains in the human population. Virology 274 (2000) 220-231